Study on Preference and Safety of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies
Latest Information Update: 15 Feb 2024
At a glance
- Drugs Mecapegfilgrastim (Primary)
- Indications Neutropenia
- Focus Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
Most Recent Events
- 15 Feb 2024 New trial record